Ciclosporin: Clinical Trials

104 trials of Ciclosporin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

75 completed, 14 terminated, 9 recruiting, 2 active not recruiting. 65 Phase 2, 24 Phase 1, 11 Phase 3, 6 Not applicable, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 265Completed 48, Terminated 7, Recruiting 6, Withdrawn 2, Active not recruiting 1, Unknown 1
Phase 124Completed 17, Terminated 4, Recruiting 2, Active not recruiting 1
Phase 311Completed 9, Terminated 2
Not applicable6Completed 5, Recruiting 1
Phase 46Completed 3, Terminated 2, Unknown 1
Early Phase 11Completed 1

Follow Ciclosporin: new trials by email Literature Review of Ciclosporin trials Research Report on Ciclosporin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood
BI 3000202, Ciclosporin, Itraconazole - Healthy
Phase 1Active not recruitingBoehringer Ingelheim162026-09-012026-10-13
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis
Slit Lamp Examination, Far Best Corrected Visual Acuity (BCVA), T1695 - Moderate to Severe Vernal Keratoconjunctivitis
Phase 2RecruitingLaboratoires Thea1202026-03-242026-04-22
RCT of Tocilizumab for Anti-MDA5+DM
Tocilizumab, Standard medical treatment - Dermatomyositis
Not applicableRecruitingPeking Union Medical College Hospital1102025-11-012026-01-29
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Aplastic Anemia
Phase 2Active not recruitingFred Hutchinson Cancer Center12025-09-252026-05-22
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Biospecimen Collection, Bone Marrow Aspirate, Cyclophosphamide - Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia
Phase 2RecruitingFred Hutchinson Cancer Center542024-07-232026-07-22
CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly
Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit - Aplastic Anemia
Phase 4CompletedPeking Union Medical College Hospital862023-09-152025-04-30
Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly
Ciclosporin, Avatrombopag - Aplastic Anemia
Phase 2UnknownPeking Union Medical College Hospital302023-08-172023-12-08
Romiplostim in Combination With CsA vs. CsA in the Treatment of Newly Diagnosed NSAA
Romiplostim, Ciclosporin - Non Severe Aplastic Anemia
Phase 4UnknownPeking Union Medical College Hospital442023-08-012023-08-24
Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia
Luspatercept, Cyclosporine - Aplastic Anemia
Phase 2CompletedBing Han582022-12-192025-09-16
A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir
Rilematovir, Ciclosporin - Healthy
Phase 1CompletedJanssen Research & Development, LLC182021-12-102025-02-03
Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
Anti-Thymocyte Globulin, Busulfan, Cyclophosphamide - Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Phase 2WithdrawnFred Hutchinson Cancer Center2021-06-012021-06-30
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cyclosporine - Acute Leukemia, Acute Lymphoblastic Leukemia
Phase 2RecruitingFred Hutchinson Cancer Center602021-01-252026-05-29
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Cladribine, Cyclophosphamide, Cyclosporine - Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelomonocytic Leukemia
Phase 1RecruitingFred Hutchinson Cancer Center1202020-12-032026-09-17
Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults
Allogeneic Hematopoietic Stem Cell Transplantation, Cyclosporine, Etoposide - Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Phase 2TerminatedM.D. Anderson Cancer Center12020-08-192025-06-29
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Total-Body Irradiation, Thiotepa, Fludarabine - Acute Leukemia, Acute Lymphoblastic Leukemia
Phase 2RecruitingFred Hutchinson Cancer Center1202019-11-192026-10-20
Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy
Ciclosporin - Dermatitis, Atopic
RecruitingFundación Academia Española de Dermatología25002019-01-012023-01-06
A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects
Semaglutide, Probenecid, Ciclosporin - Diabetes, Diabetes Mellitus, Type 2
Phase 1CompletedNovo Nordisk A/S212018-03-152019-06-19
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Cyclosporine, Fludarabine Phosphate, Mycophenolate Mofetil - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Phase 1 / Phase 2RecruitingFred Hutchinson Cancer Center752017-10-242026-06-22
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation
Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cyclosporine - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2TerminatedFred Hutchinson Cancer Center1502017-09-112026-05-14
Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Brentuximab Vedotin, Cyclosporine, Pharmacokinetic Study - Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma
Phase 1CompletedCity of Hope Medical Center292017-05-032024-02-22

Showing 20 of 104. Sign in to see all of them.

Conditions studied

Leukemia, Myeloid, Acute (35)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (31)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (28)  ·  Multiple Myeloma (24)  ·  Hodgkin Disease (23)  ·  Lymphoma, Non-Hodgkin (23)  ·  Lymphoma, Mantle-Cell (20)  ·  Lymphoma, Large B-Cell, Diffuse (19)  ·  Waldenstrom Macroglobulinemia (18)  ·  Congenital Abnormalities (17)  ·  Leukemia, Myeloid, Chronic-Phase (17)  ·  Lymphoma, B-Cell, Marginal Zone (17)  ·  Lymphoma, Follicular (17)  ·  Burkitt Lymphoma (16)  ·  Leukemia, Myelomonocytic, Chronic (16)

Sponsors

Fred Hutchinson Cancer Center (52)  ·  National Cancer Institute (NCI) (5)  ·  Case Comprehensive Cancer Center (4)  ·  London School of Hygiene and Tropical Medicine (4)  ·  Peking Union Medical College Hospital (4)  ·  Stanford University (3)  ·  M.D. Anderson Cancer Center (2)  ·  Novartis Pharmaceuticals (2)  ·  Aurinia Pharmaceuticals Inc. (1)  ·  Bing Han (1)  ·  Boehringer Ingelheim (1)  ·  Charite University, Berlin, Germany (1)  ·  City of Hope Medical Center (1)  ·  Eli Lilly and Company (1)  ·  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)

Countries

United States (72)  ·  Germany (12)  ·  Italy (11)  ·  China (5)  ·  United Kingdom (5)  ·  Ethiopia (4)  ·  Denmark (3)  ·  Canada (2)  ·  France (2)  ·  Spain (2)  ·  Sweden (2)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  India (1)

Top investigators

Brenda Sandmaier (12)  ·  David Maloney (6)  ·  Marco Mielcarek (4)  ·  Johnnie Orozco (3)  ·  Ajay Gopal (2)  ·  Ann Woolfrey (2)  ·  Colleen Delaney (2)  ·  Diana NJ Lockwood, MBChB (2)  ·  Filippo Milano (2)  ·  George Georges (2)  ·  Hans-Peter Kiem (2)  ·  Lauri Burroughs (2)  ·  Masumi Ueda Oshima (2)  ·  Robert Lowsky (2)

Results publications

PMID 32499241, PMID 18698002, PMID 19786617, PMID 19900571, PMID 21508120, PMID 21508413, PMID 21606164, PMID 22720101, PMID 23594858, PMID 26270340, PMID 26764356, PMID 27979834, PMID 28967549, PMID 29296873, PMID 30335787, PMID 30454872, PMID 30630975, PMID 31248843, PMID 31582553, PMID 31637757, PMID 32067256, PMID 32603426, PMID 32706891, PMID 32710011, PMID 33242441, PMID 35445027, PMID 37100060, PMID 41043099, PMID 42057135

NIH funding

P30CA015704 (39), P01CA018029 (13), P01CA078902 (8), P01CA044991 (4), P01HL036444 (3), 2014 (2), P30CA043703 (2), RC2HL101844 (2), 2004 (1), 2009 (1), 2017 (1), 2025 (1), K23CA190849 (1), K23HL084054 (1), P01CA049605 (1)